{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:01:49Z","timestamp":1789711309225,"version":"4.0.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1097\/01.fjc.0000185784.77520.04","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T04:02:32Z","timestamp":1132718552000},"page":"740-745","source":"Crossref","is-referenced-by-count":4,"title":["Blood Pressure and Proteinuria After Cessation of a Brief Renin-Angiotensin System Blockade in Young and Adult Lyon Hypertensive Rats"],"prefix":"10.1097","volume":"46","author":[{"given":"Ga\u00eblle","family":"Naelten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Franco","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210208","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1523-1755.2004.09201.x","article-title":"Albuminuria, not only a cardiovascular\/renal risk marker, but also a target for treatment?","volume":"66","author":"De Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"R2-4-20210208","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"R3-4-20210208","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajh\/6.2.108","article-title":"Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension.","volume":"6","author":"Bigazzi","year":"1993","journal-title":"Am J Hypertens"},{"key":"R4-4-20210208","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1681\/ASN.V124659","article-title":"Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.","volume":"12","author":"Nakaya","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R5-4-20210208","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int"},{"key":"R6-4-20210208","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00004872-199408000-00008","article-title":"Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.","volume":"12","author":"Hirawa","year":"1994","journal-title":"J Hypertens"},{"key":"R7-4-20210208","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1681\/ASN.V641295","article-title":"The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats.","volume":"6","author":"Crary","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R8-4-20210208","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/cs1000591","article-title":"Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats.","volume":"100","author":"Cao","year":"2001","journal-title":"Clin Sci"},{"key":"R9-4-20210208","first-page":"R1797","article-title":"Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in Dahl salt-sensitive rats.","volume":"274","author":"Otsuka","year":"1998","journal-title":"Am J Physiol"},{"key":"R10-4-20210208","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00004872-199311000-00004","article-title":"High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat.","volume":"11","author":"Vincent","year":"1993","journal-title":"J Hypertens"},{"key":"R11-4-20210208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00004872-199604000-00009","article-title":"Major cardiovascular risk factors in Lyon hypertensive rats. A correlation analysis in a segregating population.","volume":"14","author":"Vincent","year":"1996","journal-title":"J Hypertens"},{"key":"R12-4-20210208","first-page":"R1530","article-title":"Prostaglandin H2-Thromboxane A2 and renal functions in the Lyon hypertensive rat.","volume":"266","author":"Liu","year":"1994","journal-title":"Am J Physiol"},{"key":"R13-4-20210208","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1046\/j.1523-1755.2001.0590051865.x","article-title":"Salt sensitivity in genetically hypertensive rats of the Lyon strain.","volume":"59","author":"Florin","year":"2001","journal-title":"Kidney Int"},{"key":"R14-4-20210208","first-page":"R346","article-title":"In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent.","volume":"271","author":"Liu","year":"1996","journal-title":"Am J Physiol"},{"key":"R15-4-20210208","first-page":"R1793","article-title":"Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.","volume":"273","author":"Lantelme","year":"1997","journal-title":"Am J Physiol"},{"key":"R16-4-20210208","first-page":"R1041","article-title":"Differential evolution of blood pressure and renal lesions after renin-angiotensin system blockade in Lyon hypertensive rats.","volume":"283","author":"Bertram","year":"2002","journal-title":"Am J Physiol"},{"key":"R17-4-20210208","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.amjhyper.2004.11.033","article-title":"Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.","volume":"18","author":"Naelten","year":"2005","journal-title":"Am J Hypertens"},{"key":"R18-4-20210208","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005344-198603000-00009","article-title":"Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).","volume":"8","author":"Unger","year":"1986","journal-title":"J Cardiovasc Pharmacol"},{"key":"R19-4-20210208","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.HYP.16.6.603","article-title":"Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.","volume":"16","author":"Harrap","year":"1990","journal-title":"Hypertension"},{"key":"R20-4-20210208","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00004872-199307000-00006","article-title":"Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.","volume":"11","author":"Oddie","year":"1993","journal-title":"J Hypertens"},{"key":"R21-4-20210208","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.HYP.16.6.615","article-title":"Development of genetic hypertension: is there a critical phase?","volume":"16","author":"Unger","year":"1990","journal-title":"Hypertension"},{"key":"R22-4-20210208","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004872-199715040-00004","article-title":"Long-term inhibition of the renin-angiotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascular structural changes.","volume":"15","author":"Lundie","year":"1997","journal-title":"J Hypertens"},{"key":"R23-4-20210208","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00004872-200108000-00007","article-title":"Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.","volume":"19","author":"Paull","year":"2001","journal-title":"J Hypertens"},{"key":"R24-4-20210208","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/clinchem\/32.8.1551","article-title":"Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer.","volume":"32","author":"Watanabe","year":"1986","journal-title":"Clin Chem"},{"key":"R25-4-20210208","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.HYP.18.6.763","article-title":"Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.","volume":"18","author":"Campbell","year":"1991","journal-title":"Hypertension"},{"key":"R26-4-20210208","first-page":"F995","article-title":"Effects of dietary salt changes on renal renin-angiotensin system in rats.","volume":"283","author":"Ingert","year":"2002","journal-title":"Am J Physiol"},{"key":"R27-4-20210208","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.HYP.30.6.1471","article-title":"AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.","volume":"30","author":"Gillies","year":"1997","journal-title":"Hypertension"},{"key":"R28-4-20210208","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/00004872-200207000-00029","article-title":"Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure.","volume":"20","author":"Bergstrom","year":"2002","journal-title":"J Hypertens"},{"key":"R29-4-20210208","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005344-199308000-00021","article-title":"Losartans protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.","volume":"22","author":"Fornes","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"R30-4-20210208","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension"},{"key":"R31-4-20210208","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1681\/ASN.V124659","article-title":"Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.","volume":"12","author":"Nakaya","year":"2001","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.fjc.0000185784.77520.04","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:05Z","timestamp":1785855905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200512000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fjc.0000185784.77520.04","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}